Recombinant human NT-3 protein, glial cell line-derived neurotrophic factor, brain-derived neurotrophic factor, leukemia inhibitory factor, l-ascorbic acid, jagged 1, ciliary neurotrophic factor,…
Ended Purchase Order Awarded Last action
- Contract number
- 140D0425P0179
- Awardee
-
Research And Diagnostic Systems, Inc. UEI WAYSQU5HJYT9
- Awarding agency
-
Interior Business Center
Office of Policy Management and Budget, Department of the Interior
- Obligated
- $70,384
Award facts
- Opportunity
-
- Recombinant Human Proteins for Research and Development Special Notice · 140D0425Q0494 · Posted Aug 15, 2025
- Contract value 100% obligated
- $70,384.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Other statutory authority
Award details come from SAM.gov/FPDS.
About this award
The National Center for Advancing Translational Sciences awarded a purchase order to Research And Diagnostic Systems, Inc. for $70,384.00 on September 22, 2025, to supply recombinant human proteins and neurotrophic factors including recombinant human NT-3 protein, glial cell line-derived neurotrophic factor, brain-derived neurotrophic factor, leukemia inhibitory factor, L-ascorbic acid, jagged 1, ciliary neurotrophic factor, and XAV 939. The procurement was conducted as a sole source acquisition under FAR Part 13 simplified acquisition procedures and FAR Part 12 for commercial products. Work is performed in Rockville, Maryland. The order carries a firm fixed price and an ultimate completion date of December 31, 2025. The originating solicitation (140D0425Q0494) was posted August 15, 2025, with a closing date of August 22, 2025.
Description
Recombinant human NT-3 protein, glial cell line-derived neurotrophic factor, brain-derived neurotrophic factor, leukemia inhibitory factor, l-ascorbic acid, jagged 1, ciliary neurotrophic factor, and XAV 939.
Quick answers
Who was awarded contract 140D0425P0179?
140D0425P0179 was awarded to Research And Diagnostic Systems, Inc. by Interior Business Center (Office of Policy Management and Budget) on September 22, 2025.
How much is contract 140D0425P0179 worth?
The government has obligated $70,384 on 140D0425P0179.
Which agency awarded contract 140D0425P0179?
Interior Business Center (Office of Policy Management and Budget) awarded 140D0425P0179, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Was contract 140D0425P0179 competed?
The extent of competition for 140D0425P0179 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award